Keyphrases
Disease-free Survival
100%
Hepatocellular Carcinoma
100%
Epithelial-to-mesenchymal Transition
100%
E-cadherin
33%
Twist1
33%
Interleukin-6
33%
Chemoresistance
33%
Vimentin
33%
Epithelial Tumor
33%
Mesenchymal Tumor
33%
Tumor
22%
Transcription Factor
22%
Sorafenib
22%
Hepatocellular Carcinoma Cells
22%
In Cancer
11%
Knockdown
11%
Alpha-fetoprotein
11%
Resection
11%
Messenger RNA Expression
11%
Cancer Metastasis
11%
Cancer Invasion
11%
Putative Drug Targets
11%
Epithelial Markers
11%
Early Recurrence
11%
Early Disease
11%
Recurrent Disease
11%
Interleukin-6 Expression
11%
Zinc Finger E-box Binding Homeobox 1 (ZEB1)
11%
Mesenchymal Markers
11%
E-cadherin Expression
11%
Cadherin 2
11%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Disease Free Survival
100%
Neoplasm
71%
Uvomorulin
57%
Interleukin 6
57%
Drug Resistance
42%
Epithelium Tumor
42%
Vimentin
42%
Transcription Factors
28%
Sorafenib
28%
Recurrent Disease
28%
Malignant Neoplasm
14%
Fetoprotein
14%
Messenger RNA
14%
Biochemistry, Genetics and Molecular Biology
Mesenchymal-Epithelial Transition
100%
Disease Free Survival
100%
Interleukin 6
44%
Cadherin
44%
Vimentin
33%
Drug Resistance
33%
Transcription Factors
22%
Sorafenib
22%
Cancer Cell
11%
Cell Invasion
11%
Messenger RNA
11%
Immunology and Microbiology
Epithelial Mesenchymal Transition
100%
Disease Free Survival
100%
Interleukin 6
44%
Cadherin
44%
Drug Resistance
33%
Transcription Factors
22%
Sorafenib
22%
Hepatocellular Carcinoma Cell Line
22%
Cancer Cell
11%
Cell Invasion
11%